journal article·2021-01-11

Metformin-Loaded PCL/PVA Fibrous Scaffold Preseeded with Human Endometrial Stem Cells for Effective Guided Bone Regeneration Membranes

Lida Ebrahimi, Ali Farzin, Younes Ghasemi, Aliakbar Alizadeh, Arash Goodarzi, Arefeh Basiri, Maria Zahiri, Ahmad Monabati, Jafar Ai

Publisher page

Abstract

Many studies have been devoted to investigating the potential of guided bone regeneration (GBR) membranes for bone defect reconstruction. Regardless of approaches for treating damaged bone tissues, a beneficial therapeutic strategy has remained a challenge. In this study, a novel GBR membrane with polycaprolactone (PCL) and poly(vinyl alcohol) (PVA) containing different concentrations of metformin (Met) for improving osteogenic properties was developed. The membranes were evaluated for their hydrophilicity, degradation rate, swelling ratio, drug release, mechanical properties, and biological responses. The results showed a significant increase in hydrophilicity, swelling ratio, and degradation rate and no significant changes in mechanical properties of PCL/PVA membranes with Met concentration enhancement. A decrease in cell viability cultured on the surface of the PCL/PVA membrane was seen when the amount of Met was changed from 10 to 15 wt %. The results of the in vitro quantitative real-time polymerase chain reaction (qRT-PCR) also confirmed the higher secretion of osteogenic-related genes in a PCL/PVA/Cell/10 wt % Met scaffold than in the PCL/PVA/Cell sample. Therefore, further in vivo studies were conducted using the electrospun PCL/PVA membrane containing human endometrial stem cells (hEnSCs) and 10% Met. Histopathological and histomorphometric results confirmed that PCL/PVA/hEnSCs/10 wt % Met has excellent potential to differentiate hEnSCs into osteogenic lineages and bone regeneration in calvarial defects of rats. The results of this study confirm the high potential of the PCL/PVA/10 wt % Met fibrous membrane preseeded with hEnSCs in GBR applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Mesenchymal stem cell research · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Tissue Engineering, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa 7461686688, Iran

Department of Tissue Engineering, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran

Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 5546914177, Iran

Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran

Department of Biomaterials and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran

The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran

Department of Anatomical Sciences, School of Medical Sciences, Bushehr University of Medical Sciences, Bushehr 7518759577, Iran

Department of Pathology and Hematology Science Research Center, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran

Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran 1449614535, Iran

Funding

Shiraz University of Medical Sciences

References (53)

Show source-provided references
1. 10.1111/j.1600-051X.1980.tb01952.x10.1111/j.1600-051X.1980.tb01952.x ↗
2. 10.1002/biot.20110029410.1002/biot.201100294 ↗
3. 10.1111/j.1600-0501.2010.01922.x10.1111/j.1600-0501.2010.01922.x ↗
4. 10.3390/ijms1503364010.3390/ijms15033640 ↗
5. 10.1016/j.jmatprotec.2006.07.01610.1016/j.jmatprotec.2006.07.016 ↗
6. 10.1096/fj.201801797R10.1096/fj.201801797R ↗
7. 10.4103/0971-5916.15924410.4103/0971-5916.159244 ↗
8. 10.1155/2016/161573510.1155/2016/1615735 ↗
9. 10.1016/j.ejphar.2006.02.03010.1016/j.ejphar.2006.02.030 ↗
10. 10.1620/tjem.241.1310.1620/tjem.241.13 ↗
11. 10.1016/j.ejphar.2010.02.05110.1016/j.ejphar.2010.02.051 ↗
12. 10.3390/jcm712048210.3390/jcm7120482 ↗
13. 10.1359/jbmr.09073210.1359/jbmr.090732 ↗
14. 10.1177/193371911350340510.1177/1933719113503405 ↗
15. 10.1007/s11010-014-2109-010.1007/s11010-014-2109-0 ↗
16. 10.1002/jbm.a.3492110.1002/jbm.a.34921 ↗
17. 10.1093/humrep/dem26510.1093/humrep/dem265 ↗
18. 10.1095/biolreprod.108.07522610.1095/biolreprod.108.075226 ↗
19. Ai J. · J. Reprod. Infertil. · 2012 · 13 · 151
20. Ai J. · Iran. Red Crescent Med. J. · 2010 · 12 · 585
21. Doustgani A. · Int. J. Nanosci. Nanotechnol. · 2011 · 7 · 127
22. 10.1177/088391151772480910.1177/0883911517724809 ↗
23. 10.3109/21691401.2015.102962910.3109/21691401.2015.1029629 ↗
24. Ai J. · J. Reprod. Infertil. · 2012 · 13 · 151
25. 10.1016/j.biomaterials.2015.02.03310.1016/j.biomaterials.2015.02.033 ↗
26. 10.1016/j.pmatsci.2005.05.00210.1016/j.pmatsci.2005.05.002 ↗
27. 10.1016/j.jcis.2004.02.00110.1016/j.jcis.2004.02.001 ↗
28. Tavares M. I. B. · Mater. Sci. Appl. · 2016 · 7 · 575
29. 10.2147/IJN.S2537610.2147/IJN.S25376 ↗
30. 10.5402/2012/36426110.5402/2012/364261 ↗
31. 10.1016/S0300-9440(99)00005-310.1016/S0300-9440(99)00005-3 ↗
32. 10.1208/s12249-018-0975-610.1208/s12249-018-0975-6 ↗
33. Jin R. M. · J. Nanomater. · 2015 · 16 · 138
34. 10.1038/s41598-017-10169-510.1038/s41598-017-10169-5 ↗
35. 10.1039/C8TB02435A10.1039/C8TB02435A ↗
36. 10.1038/s41598-017-07759-810.1038/s41598-017-07759-8 ↗
37. 10.1007/s40204-018-0098-x10.1007/s40204-018-0098-x ↗
38. 10.1039/C8TB02435A10.1039/C8TB02435A ↗
39. 10.1021/acsami.7b0117610.1021/acsami.7b01176 ↗
40. 10.1007/s40204-017-0062-110.1007/s40204-017-0062-1 ↗
41. 10.1002/jbm.a.3010010.1002/jbm.a.30100 ↗
42. Mathews D. · J. Biomed. Mater. Res., Part B · 2008 · 84 · 53110.1002/jbm.b.30901 ↗
43. 10.1016/j.mattod.2013.06.00510.1016/j.mattod.2013.06.005 ↗
44. 10.1016/j.nano.2018.06.00710.1016/j.nano.2018.06.007 ↗
45. 10.2147/IJN.S6137510.2147/IJN.S61375 ↗
46. 10.1016/j.biomaterials.2006.08.02210.1016/j.biomaterials.2006.08.022 ↗
47. 10.1016/j.biomaterials.2004.01.06610.1016/j.biomaterials.2004.01.066 ↗
48. 10.1016/j.biomaterials.2006.08.02210.1016/j.biomaterials.2006.08.022 ↗
49. 10.1016/j.biomaterials.2010.11.07810.1016/j.biomaterials.2010.11.078 ↗
50. 10.3389/fbioe.2019.0020610.3389/fbioe.2019.00206 ↗
51. 10.1016/j.biomaterials.2013.09.04010.1016/j.biomaterials.2013.09.040 ↗
52. 10.1902/jop.2009.09041410.1902/jop.2009.090414 ↗
53. 10.1359/jbmr.09073210.1359/jbmr.090732 ↗